Terms: = Pancreatic cancer AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2 AND Prognosis
24 results:
1. SLC38A5 Modulates Ferroptosis to Overcome Gemcitabine Resistance in pancreatic cancer.
Kim MJ; Kim HS; Kang HW; Lee DE; Hong WC; Kim JH; Kim M; Cheong JH; Kim HJ; Park JS
Cells; 2023 Oct; 12(20):. PubMed ID: 37887353
[TBL] [Abstract] [Full Text] [Related]
2. STAT3 inhibition enhances gemcitabine sensitivity in pancreatic cancer by suppressing EMT, immune escape and inducing oxidative stress damage.
Guo H; Hu Z; Yang X; Yuan Z; Gao Y; Chen J; Xie L; Chen C; Guo Y; Bai Y
Int Immunopharmacol; 2023 Oct; 123():110709. PubMed ID: 37515849
[TBL] [Abstract] [Full Text] [Related]
3. Cinchonine-induced cell death in pancreatic cancer cells by downregulating RRP15.
Liang F; Lv Y; Qiao X; Zhang S; Shen S; Wang C; Xu G; Zou X; Wang L; Zhang B
Cell Biol Int; 2023 May; 47(5):907-919. PubMed ID: 36682038
[TBL] [Abstract] [Full Text] [Related]
4. Exploration and validation of a novel ferroptosis-related gene signature predicting the prognosis of intrahepatic cholangiocarcinoma.
Yao X; Chen B; Wang M; Zhang S; He B; Shi Z; Deng T; Bao W; Wang Y; Chen G; Bo Z
Acta Biochim Biophys Sin (Shanghai); 2022 Sep; 54(9):1376-1385. PubMed ID: 36111744
[TBL] [Abstract] [Full Text] [Related]
5. Brucein D augments the chemosensitivity of gemcitabine in pancreatic cancer via inhibiting the nrf2 pathway.
Zhang J; Xu HX; Cho WCS; Cheuk W; Li Y; Huang QH; Yang W; Xian YF; Lin ZX
J Exp Clin Cancer Res; 2022 Mar; 41(1):90. PubMed ID: 35272669
[TBL] [Abstract] [Full Text] [Related]
6. MGST1 is a redox-sensitive repressor of ferroptosis in pancreatic cancer cells.
Kuang F; Liu J; Xie Y; Tang D; Kang R
Cell Chem Biol; 2021 Jun; 28(6):765-775.e5. PubMed ID: 33539732
[TBL] [Abstract] [Full Text] [Related]
7. Pan-cancer Multiomics Analysis of TC2N Gene Suggests its Important Role(s) in Tumourigenesis of Many cancers.
Qureshi MA; Khan S; Tauheed MS; Syed SA; Ujjan ID; Lail A; Sharafat S
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3199-3209. PubMed ID: 33247676
[TBL] [Abstract] [Full Text] [Related]
8. Undermining Glutaminolysis Bolsters Chemotherapy While nrf2 Promotes Chemoresistance in KRAS-Driven pancreatic cancers.
Mukhopadhyay S; Goswami D; Adiseshaiah PP; Burgan W; Yi M; Guerin TM; Kozlov SV; Nissley DV; McCormick F
Cancer Res; 2020 Apr; 80(8):1630-1643. PubMed ID: 31911550
[TBL] [Abstract] [Full Text] [Related]
9. HEATR1 deficiency promotes pancreatic cancer proliferation and gemcitabine resistance by up-regulating nrf2 signaling.
Zhou Y; Wang K; Zhou Y; Li T; Yang M; Wang R; Chen Y; Cao M; Hu R
Redox Biol; 2020 Jan; 29():101390. PubMed ID: 31785531
[TBL] [Abstract] [Full Text] [Related]
10. New addiction to the nrf2-related factor NRF3 in cancer cells: Ubiquitin-independent proteolysis through the 20S proteasome.
Kobayashi A; Waku T
Cancer Sci; 2020 Jan; 111(1):6-14. PubMed ID: 31742837
[TBL] [Abstract] [Full Text] [Related]
11. NO
Wang L; Tang W; Yang S; He P; Wang J; Gaedcke J; Ströbel P; Azizian A; Ried T; Gaida MM; Yfantis HG; Lee DH; Lal A; Van den Eynde BJ; Alexander HR; Ghadimi BM; Hanna N; Hussain SP
Int J Cancer; 2020 Jun; 146(11):3160-3169. PubMed ID: 31609478
[TBL] [Abstract] [Full Text] [Related]
12. Variants in oxidative stress-related genes affect the chemosensitivity through nrf2-mediated signaling pathway in biliary tract cancer.
Zhan M; Wang H; Xu SW; Yang LH; Chen W; Zhao SX; Shen H; Liu Q; Yang RM; Wang J
EBioMedicine; 2019 Oct; 48():143-160. PubMed ID: 31590928
[TBL] [Abstract] [Full Text] [Related]
13. The protein kinase activity of fructokinase A specifies the antioxidant responses of tumor cells by phosphorylating p62.
Xu D; Li X; Shao F; Lv G; Lv H; Lee JH; Qian X; Wang Z; Xia Y; Du L; Zheng Y; Wang H; Lyu J; Lu Z
Sci Adv; 2019 Apr; 5(4):eaav4570. PubMed ID: 31032410
[TBL] [Abstract] [Full Text] [Related]
14. nrf2 in cancers: A double-edged sword.
Wu S; Lu H; Bai Y
Cancer Med; 2019 May; 8(5):2252-2267. PubMed ID: 30929309
[TBL] [Abstract] [Full Text] [Related]
15. aPKCι promotes gallbladder cancer tumorigenesis and gemcitabine resistance by competing with nrf2 for binding to Keap1.
Tian L; Lu Y; Yang T; Deng Z; Xu L; Yao W; Ma C; Li X; Zhang J; Liu Y; Wang J
Redox Biol; 2019 Apr; 22():101149. PubMed ID: 30822690
[TBL] [Abstract] [Full Text] [Related]
16. PIN1 Maintains Redox Balance via the c-Myc/nrf2 Axis to Counteract Kras-Induced Mitochondrial Respiratory Injury in pancreatic cancer Cells.
Liang C; Shi S; Liu M; Qin Y; Meng Q; Hua J; Ji S; Zhang Y; Yang J; Xu J; Ni Q; Li M; Yu X
Cancer Res; 2019 Jan; 79(1):133-145. PubMed ID: 30355620
[TBL] [Abstract] [Full Text] [Related]
17. GRP78-mediated antioxidant response and ABC transporter activity confers chemoresistance to pancreatic cancer cells.
Dauer P; Sharma NS; Gupta VK; Nomura A; Dudeja V; Saluja A; Banerjee S
Mol Oncol; 2018 Sep; 12(9):1498-1512. PubMed ID: 29738634
[TBL] [Abstract] [Full Text] [Related]
18. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/nrf2 pathway in pancreatic cancer cells.
Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
[TBL] [Abstract] [Full Text] [Related]
19. Activation of AKT pathway by nrf2/PDGFA feedback loop contributes to HCC progression.
Liu D; Zhang Y; Wei Y; Liu G; Liu Y; Gao Q; Zou L; Zeng W; Zhang N
Oncotarget; 2016 Oct; 7(40):65389-65402. PubMed ID: 27588483
[TBL] [Abstract] [Full Text] [Related]
20. ALDOA functions as an oncogene in the highly metastatic pancreatic cancer.
Ji S; Zhang B; Liu J; Qin Y; Liang C; Shi S; Jin K; Liang D; Xu W; Xu H; Wang W; Wu C; Liu L; Liu C; Xu J; Ni Q; Yu X
Cancer Lett; 2016 Apr; 374(1):127-135. PubMed ID: 26854714
[TBL] [Abstract] [Full Text] [Related]
[Next]
